Seagen Inc.
ADCS WITH THIOL MULTIPLEX LINKERS
Last updated:
Abstract:
The present disclosure provides, inter alia, thiol multiplexed Antibody Drug Conjugates (TM-ADCs) and Multiplex Linking Assemblies (MLAs) that comprise multiple Drug Moieties in a single linking assembly.
Status:
Application
Type:
Utility
Filling date:
20 Dec 2019
Issue date:
10 Feb 2022